Tetraphase pharmaceuticals inc (TTPH)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12
Revenues:
Total revenue

7,858

7,376

9,969

7,780

18,286

18,904

17,149

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Expenses:
Total revenues

-

-

-

-

-

-

-

-

-

-

8,228

5,011

4,668

5,145

6,526

8,532

10,632

11,686

12,287

11,725

9,657

9,098

7,924

7,796

10,243

10,486

11,828

12,199

9,793

7,600

0

0

0

Research and development

17,941

22,785

30,968

37,285

43,489

54,879

62,631

79,743

93,886

101,706

102,542

90,955

76,188

63,764

59,475

59,257

68,418

73,768

78,479

74,695

68,301

61,932

52,699

49,503

39,914

31,508

25,627

20,054

17,391

17,294

0

0

0

Selling, general and administrative

46,397

49,043

54,504

52,635

44,687

37,078

30,228

26,347

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total expenses

68,614

74,908

87,348

90,816

88,666

92,185

92,859

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative

-

-

-

-

-

-

-

-

-

-

-

19,397

19,091

19,211

20,457

19,536

21,266

20,916

19,057

18,206

14,664

12,932

11,531

10,305

9,114

7,168

6,170

5,327

4,573

4,309

0

0

0

Total operating expenses

-

-

-

-

-

-

-

-

-

-

122,681

110,352

95,279

82,975

79,932

78,793

89,684

94,684

97,536

92,901

82,965

74,864

64,230

59,808

49,028

38,676

31,797

25,381

21,964

21,603

0

0

0

Loss from operations

-60,756

-67,532

-77,379

-83,036

-70,380

-73,281

-75,710

-86,025

-108,061

-115,715

-114,453

-105,341

-90,611

-77,830

-73,406

-70,261

-79,052

-82,998

-85,249

-81,176

-73,308

-65,766

-56,306

-52,012

-38,785

-28,190

-19,969

-13,182

-12,171

-14,003

0

0

0

Other income and expenses
Loss on extinguishment of debt

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income

0

0

-

0

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

824

1,262

1,707

1,892

1,889

1,747

1,558

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

-

-

-

-

-

Interest expense

-

2,580

3,204

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,622

1,719

1,703

1,472

1,218

1,021

0

0

0

Other income (expense)

-

-

-

-

-

-

-

-

-

-

-

-

-

350

271

192

108

-191

0

0

0

-

-

-

24

263

286

181

0

-

0

0

-

Other income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-976

-1,189

-1,393

-1,583

-1,446

-1,416

-1,165

-1,018

-1,084

0

0

0

Net loss

-62,721

-70,085

-80,194

-83,448

-70,070

-72,158

-74,152

-84,602

-106,870

-114,752

-113,738

-104,840

-90,197

-77,480

-73,135

-70,069

-78,944

-83,189

-85,623

-81,785

-74,205

-66,742

-57,495

-53,405

-40,368

-29,636

-21,385

-14,347

-13,189

-15,087

0

0

0

Net loss per share-basic and diluted

-1.31

-2.75

-6.00

-8.45

-7.25

-8.00

-7.39

-0.18

-0.42

-0.46

-0.63

-0.83

-0.79

-0.60

-0.58

-0.47

-0.46

-0.49

-0.49

-0.72

-0.66

-0.70

-0.55

-0.71

-0.53

0.48

-0.49

-0.26

-1.51

-23.97

-9.63

-13.42

-0.52

Weighted-average number of common shares used in net loss per share-basic and diluted

9,273

4,150

-99,900

105,331

2,687

-95,583

2,647

51,839

51,601

51,615

47,347

38,273

37,093

36,897

36,692

36,629

36,598

36,624

36,463

36,207

31,750

29,682

25,967

25,845

25,734

23,563

20,674

20,575

1,848

-8,308

320

318

8,938

Comprehensive loss

-62,721

-70,085

-80,194

-83,448

-70,070

-72,158

-74,152

-84,602

-106,870

-114,752

-113,738

-104,840

-90,197

-77,480

-73,135

-70,069

-78,944

-83,189

-85,623

-81,785

-74,205

-66,742

-57,495

-53,405

-40,368

-29,636

-21,385

-14,347

-13,189

-15,087

0

0

0

Product Revenue, net [Member]
Total revenue

4,989

3,575

2,293

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of revenue

3,883

2,687

1,483

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License and Collaboration Revenue [Member]
Total revenue

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Government Revenue [Member]
Total revenue

-

1,801

2,499

3,288

5,090

6,049

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible asset amortization [Member]
Cost of revenue

393

393

393

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-